ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

British Journal of Cancer ◽

10.1038/sj.bjc.6600182 ◽

2002 ◽

Vol 86 (7) ◽

pp. 1157-1161 ◽

Author(s):

K J Williams ◽

B A Telfer ◽

I J Stratford ◽

S R Wedge

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Xenograft Model ◽

Growth Factor Receptor ◽

Human Colorectal Cancer ◽

Epidermal Growth

Download Full-text

A phase II trial of ZD1839 (Iressa?) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer

Investigational New Drugs ◽

10.1007/s10637-005-5862-9 ◽

2005 ◽

Vol 23 (2) ◽

pp. 165-170 ◽

Author(s):

Mary J. MacKenzie ◽

Holger W. Hirte ◽

Goss Glenwood ◽

Maroun Jean ◽

Rakesh Goel ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Phase Ii Trial ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

KRASstatus and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis

Colorectal Disease ◽

10.1111/codi.12749 ◽

2014 ◽

Vol 16 (11) ◽

pp. O370-O378 ◽

Author(s):

W. Li ◽

Q. Shi ◽

W. Wang ◽

J. Liu ◽

J. Ren ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD1839 (‘Iressa’), in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in advanced colorectal cancer (ACRC)

European Journal of Cancer ◽

10.1016/s0959-8049(01)80551-7 ◽

2001 ◽

Vol 37 ◽

pp. S18-S19 ◽

Author(s):

L. Hammond ◽

J. Figueroa ◽

L. Schwartzberg ◽

L. Ochoa ◽

M. Hidalgo ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Advanced Colorectal Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Download Full-text

Efficacy of Cetuximab After Treatment with Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor—Based Chemotherapy in Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.3816/ccc.2006.n.022 ◽

2006 ◽

Vol 6 (1) ◽

pp. 59-65 ◽

Author(s):

Jeffrey A. Meyerhardt ◽

Denise Heseltine ◽

Shuji Ogino ◽

Jeffrey W. Clark ◽

Peter C. Enzinger ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters

Cancer Science ◽

10.1111/cas.13266 ◽

2017 ◽

Vol 108 (7) ◽

pp. 1368-1377 ◽

Author(s):

Kei Kunimasa ◽

Tatsuya Nagano ◽

Yohei Shimono ◽

Ryota Dokuni ◽

Tatsunori Kiriu ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Targeted Therapy ◽

Growth Factor ◽

Glucose Metabolism ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Withaferin A ◽

Epidermal Growth

Download Full-text

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"1

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01464.x ◽

2003 ◽

Vol 94 (5) ◽

pp. 453-458 ◽

Author(s):

Seiji Yano ◽

Takanori Kanematsu ◽

Toyokazu Miki ◽

Yoshinori Aono ◽

Masahiko Azuma ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bronchioloalveolar Carcinoma ◽

Epidermal Growth

Download Full-text

Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

10.1158/1538-7445.am2021-419 ◽

2021 ◽

Author(s):

Yalin Xie ◽

Wei Zhou ◽

An Lei ◽

Zhan Huang ◽

Li Weiwei ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Pulmonary Tuberculosis ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0993 ◽

2005 ◽

Vol 11 (4) ◽

pp. 1572-1578 ◽

Author(s):

Qun Dai ◽

Yi-He Ling ◽

Marie Lia ◽

Yi-Yu Zou ◽

Glenn Kroog ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Tumor Cell Lines ◽

Enhanced Sensitivity ◽

Epidermal Growth

Download Full-text